Spyre Therapeutics Inc.
SYRE
$107.36+0.67%
End of day · as of Aug 25, 2026, 7:20 PM ET
Mkt cap
$7.60B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (H1 2026)
$-1.09
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
Use this SYRE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SYRE income, balance, and cash tables.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company in the Healthcare sector.
Latest cached Spyre Therapeutics Inc. (SYRE) net income for Dec 31, 2025 was -$155.2M. Statements: https://lician.com/financials/syre
Spyre Therapeutics Inc. (SYRE) market capitalization is $7.60B on the latest cached snapshot.
Spyre Therapeutics Inc. (SYRE) cached previous close $106.65; day range $106.94 – $110.15; volume 808,012. Session quote: https://lician.com/quote/syre
Spyre Therapeutics Inc. (SYRE) latest cached earnings event is "SYRE earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SYRE filing is 8-K · Oct 7, 2026. Filings: https://lician.com/sec/syre